Since qualifying in August 2023, Sean has advised on various profiles of transactions in the Life Science and Technology sectors. Sean has experience advising on M&A transactions, including share sales and asset sales. Sean has also advised on investments in emerging companies on both the company side and investor side.

Sean’s work highlights include:

• Acting for pharmaceutical companies, academic and research institutions, venture capital investors, biotechnology companies, technology companies, media companies.
• Advising on share sales, asset sales, financing rounds, debt financing.

Sean spent three months on secondment at GSK in the Corporate & Business Development team.

Sean completed a Bachelor of Science with a major in biochemistry and a minor in business at McGill University in Montreal, Canada. At McGill, Sean also worked as a laboratory technician in a structural biology lab on projects designed to better understand the causes of neurological disease.

Sean is fluent in French.